Agreeing to Submission Document Timelines & Sticking to Them: Fairy Tale or Reality?
In this webinar, Steve Sibley defined best practices for establishing submission timelines that won’t change,…
Certara2017 年 9 月 14 日
Drug Asset Evaluation: Increasing “Probability of Success” of a Deal
Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…
Certara2017 年 8 月 24 日
Investigational Drug Gap Analysis
As the process of drug development has increased in cost and complexity, Certara has developed…
Certara2017 年 8 月 14 日
Clinical Pharmacology—The Quarterback of Drug Development
Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…
Certara2017 年 8 月 14 日
